Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.10

Ardelyx reported $244.35M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 540M 1000K Mar/2026
Ardelyx USD 244.35M 1.38M Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Curis USD 12.93M 12.87M Dec/2025
TG Therapeutics USD 155.31M 95K Dec/2025
United Therapeutics USD 42.16M 1.49M Mar/2026
Xoma USD 87K 1000 Jun/2024